<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891146</url>
  </required_header>
  <id_info>
    <org_study_id>AbdurrahmanYAOTRH</org_study_id>
    <nct_id>NCT04891146</nct_id>
  </id_info>
  <brief_title>The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries</brief_title>
  <official_title>The Effect of Inhalation Anesthesia and Total Intravenous Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effects of different anesthesia methods on the immune system are variable. In this study,&#xD;
      we investigated the effect of inhalation anesthesia and total intravenous anesthesia on the&#xD;
      SII value in major abdominal cancer surgeries.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was planned prospectively, observationally, on a total of 90 patients who underwent&#xD;
      major abdominal cancer surgery. 84 patients were evaluated. The patients were seperated in&#xD;
      two groups as inhalation anesthesia and total intravenous anesthesia (TIVA). The demographic&#xD;
      data of the patients, type of cancer, type of surgery performed, ASA classification,&#xD;
      preoperative chemotherapy intake, preoperative hemogram, postoperative 2nd and 24th hour&#xD;
      hemogram, intraoperative and postoperative blood transfusion, and duration of surgery were&#xD;
      recorded. Platelet, neutrophil, lymphocyte and SII values were saved.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 5, 2020</start_date>
  <completion_date type="Actual">December 12, 2020</completion_date>
  <primary_completion_date type="Actual">September 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>investigate the effect of anesthesia management on the change of preoperative systemic inflammatory immune index(SII) and postoperative 2.hour and 24.hour SII value</measure>
    <time_frame>preoperative SII noted, postoperative 2.hour noted and postoperative 24.hour noted</time_frame>
    <description>systemic inflammatory immune index calculated by (platelet x neutrophil)/lymphocyte</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Systemic Immune Activation</condition>
  <condition>Cancer Gi</condition>
  <condition>Cancer of Endometrium</condition>
  <arm_group>
    <arm_group_label>Inhalation anesthesia</arm_group_label>
    <description>Sevoflurane for opioid remifentanyl used</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Intravenous Anesthesia</arm_group_label>
    <description>Propofol for opioid remifentanyl used</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Systemic inflammatory immmune index</intervention_name>
    <description>Systemic Inflammatory Immune index calculated from platelet, neutrophil and lymphocyte count</description>
    <arm_group_label>Inhalation anesthesia</arm_group_label>
    <arm_group_label>Total Intravenous Anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        major abdominal cancer patients between 18-85 years included. 40 patients in sevoflurane&#xD;
        group and 44 patients in TIVA group collected&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  major abdominal cancer surgeries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  blood transfusion in last 72 hours&#xD;
&#xD;
          -  patients with infection&#xD;
&#xD;
          -  hematologic malignancy&#xD;
&#xD;
          -  patient controlled analgesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arsen Gungor</last_name>
    <role>Principal Investigator</role>
    <affiliation>arsen.gungor@hotmail.com</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Abdurrahman Yurtaslan Oncology Research and Trainee Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Yenimahalle</state>
        <zip>06200</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. doi: 10.1158/1078-0432.CCR-14-0442. Epub 2014 Sep 30.</citation>
    <PMID>25271081</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016 Apr;69(2):126-32. doi: 10.4097/kjae.2016.69.2.126. Epub 2016 Mar 30.</citation>
    <PMID>27066202</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>May 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 14, 2021</last_update_submitted>
  <last_update_submitted_qc>May 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Arsen Güngör</investigator_full_name>
    <investigator_title>Anesthesiology and Reanimation Specialist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>shared after published</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

